476 related articles for article (PubMed ID: 18620577)
1. Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up.
Adjei GO; Kurtzhals JA; Rodrigues OP; Alifrangis M; Hoegberg LC; Kitcher ED; Badoe EV; Lamptey R; Goka BQ
Malar J; 2008 Jul; 7():127. PubMed ID: 18620577
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of artemether + lumefantrine, artesunate + sulphamethoxypyrazine-pyrimethamine and artesunate + amodiaquine and sulphadoxine-pyrimethamine + amodiaquine in the treatment of uncomplicated falciparum malaria in Bangui, Central African Republic: a randomized trial.
Djallé D; Njuimo SP; Manirakiza A; Laganier R; Le Faou A; Rogier C
Malar J; 2014 Jan; 13():9. PubMed ID: 24393479
[TBL] [Abstract][Full Text] [Related]
3. In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated falciparum malaria in children: a multisite, open-label, two-cohort, clinical trial in Mozambique.
Nhama A; Bassat Q; Enosse S; Nhacolo A; Mutemba R; Carvalho E; Naueia E; Sevene E; Guinovart C; Warsame M; Sanz S; Mussa A; Matsinhe G; Alonso P; Tiago A; Macete E
Malar J; 2014 Aug; 13():309. PubMed ID: 25108397
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial on effectiveness of artemether-lumefantrine versus artesunate plus amodiaquine for unsupervised treatment of uncomplicated Plasmodium falciparum malaria in Ghanaian children.
Kobbe R; Klein P; Adjei S; Amemasor S; Thompson WN; Heidemann H; Nielsen MV; Vohwinkel J; Hogan B; Kreuels B; Bührlen M; Loag W; Ansong D; May J
Malar J; 2008 Dec; 7():261. PubMed ID: 19099594
[TBL] [Abstract][Full Text] [Related]
5. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
6. Randomized non-inferiority and safety trial of dihydroartemisin-piperaquine and artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroonian children.
Nji AM; Ali IM; Moyeh MN; Ngongang EO; Ekollo AM; Chedjou JP; Ndikum VN; Evehe MS; Froeschl G; Heumann C; Mansmann U; Ogundahunsi O; Mbacham WF
Malar J; 2015 Jan; 14():27. PubMed ID: 25626448
[TBL] [Abstract][Full Text] [Related]
7. Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial.
Ndiaye JL; Faye B; Gueye A; Tine R; Ndiaye D; Tchania C; Ndiaye I; Barry A; Cissé B; Lameyre V; Gaye O
Malar J; 2011 Aug; 10():237. PubMed ID: 21838909
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children.
Maiteki-Sebuguzi C; Jagannathan P; Yau VM; Clark TD; Njama-Meya D; Nzarubara B; Talisuna AO; Kamya MR; Rosenthal PJ; Dorsey G; Staedke SG
Malar J; 2008 Jun; 7():106. PubMed ID: 18547415
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of fixed-dose artesunate-amodiaquine vs. artemether-lumefantrine for repeated treatment of uncomplicated malaria in Ugandan children.
Yeka A; Lameyre V; Afizi K; Fredrick M; Lukwago R; Kamya MR; Talisuna AO
PLoS One; 2014; 9(12):e113311. PubMed ID: 25436614
[TBL] [Abstract][Full Text] [Related]
10. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
[TBL] [Abstract][Full Text] [Related]
11. An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria.
Owusu-Agyei S; Asante KP; Owusu R; Adjuik M; Amenga-Etego S; Dosoo DK; Gyapong J; Greenwood B; Chandramohan D
PLoS One; 2008 Jun; 3(6):e2530. PubMed ID: 18575626
[TBL] [Abstract][Full Text] [Related]
12. Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.
Ndiaye JL; Randrianarivelojosia M; Sagara I; Brasseur P; Ndiaye I; Faye B; Randrianasolo L; Ratsimbasoa A; Forlemu D; Moor VA; Traore A; Dicko Y; Dara N; Lameyre V; Diallo M; Djimde A; Same-Ekobo A; Gaye O
Malar J; 2009 Jun; 8():125. PubMed ID: 19505304
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania.
Kabanywanyi AM; Mwita A; Sumari D; Mandike R; Mugittu K; Abdulla S
Malar J; 2007 Nov; 6():146. PubMed ID: 17996121
[TBL] [Abstract][Full Text] [Related]
14. Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia.
Schramm B; Valeh P; Baudin E; Mazinda CS; Smith R; Pinoges L; Sundaygar T; Zolia YM; Jones JJ; Comte E; Bruneel A; Branger M; Jullien V; Carn G; Kiechel JR; Ashley EA; Guérin PJ
Malar J; 2013 Jul; 12():250. PubMed ID: 23866736
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of artesunate-amodiaquine versus artemether-lumefantrine for home-based treatment of uncomplicated Plasmodium falciparum malaria among children 6-120 months in Yaoundé, Cameroon: a randomized trial.
Niba PTN; Nji AM; Ali IM; Akam LF; Dongmo CH; Chedjou JPK; Fomboh CT; Nana WD; Oben OLA; Selly-Ngaloumo AA; Moyeh MN; Ngu JA; Ludovic AJ; Aboh PM; Ambani MCE; Omgba PAM; Kotcholi GB; Adzemye LM; Nna DRA; Douanla A; Ango Z; Ewane MS; Ticha JT; Tatah FM; Dinza G; Ndikum VN; Fosah DA; Bigoga JD; Alifrangis M; Mbacham WF
BMC Infect Dis; 2022 Feb; 22(1):166. PubMed ID: 35189818
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of the efficacies and tolerabilities of three artemisinin-based combination treatments for children with acute Plasmodium falciparum malaria in the Democratic Republic of the Congo.
Onyamboko MA; Fanello CI; Wongsaen K; Tarning J; Cheah PY; Tshefu KA; Dondorp AM; Nosten F; White NJ; Day NP
Antimicrob Agents Chemother; 2014 Sep; 58(9):5528-36. PubMed ID: 25001306
[TBL] [Abstract][Full Text] [Related]
17. In vivo efficacy and safety of artemether-lumefantrine and amodiaquine-artesunate for uncomplicated Plasmodium falciparum malaria in Mozambique, 2018.
Nhama A; Nhamússua L; Macete E; Bassat Q; Salvador C; Enosse S; Candrinho B; Carvalho E; Nhacolo A; Chidimatembue A; Saifodine A; Zulliger R; Lucchi N; Svigel SS; Moriarty LF; Halsey ES; Mayor A; Aide P
Malar J; 2021 Oct; 20(1):390. PubMed ID: 34600544
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy and effects of artesunate-amodiaquine and artemether-lumefantrine on malaria-associated anaemia in Nigerian children aged two years and under.
Sowunmi A; Akano K; Ayede AI; Ntadom G; Adewoye EO; Fatunmbi B; Aderoyeje T
Infect Dis Poverty; 2016 Jul; 5(1):70. PubMed ID: 27384596
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of artesunate-amodiaquine (Camoquin plus) versus artemether-lumefantrine (Coartem) against uncomplicated Plasmodium falciparum malaria: multisite trial in Senegal and Ivory Coast.
Faye B; Offianan AT; Ndiaye JL; Tine RC; Touré W; Djoman K; Sylla K; Ndiaye PS; Penali L; Gaye O
Trop Med Int Health; 2010 May; 15(5):608-13. PubMed ID: 20214761
[TBL] [Abstract][Full Text] [Related]
20. In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014.
Paczkowski M; Mwandama D; Marthey D; Luka M; Makuta G; Sande J; Ali D; Troell P; Mathanga DP; Gutman J
Malar J; 2016 Apr; 15():236. PubMed ID: 27113085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
